Simon Haefliger

915 citations
33 papers · 646 · 1 hit paper · h-index 13

Impact in

    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
  • Hematology top 5%
    • Acute Myeloid Leukemia Research

Papers in

    • Cancer Genomics and Diagnostics 8
    • Cancer-related molecular mechanisms research 4
    • MicroRNA in disease regulation 3
    • RNA Research and Splicing 3

Simon Haefliger

33 papers receiving 633 citations

Simon Haefliger's Hit Papers

Targeting and engineering long non-coding RNAs for cancer therapy 2024 · 118 citations
1180+1Years since publication255075100

Peers

Simon Haefliger
Comparison fields: 5 of 72
  • Cancer Research 198
  • Hematology 134
  • Genetics 59
  • Molecular Biology 313
  • Oncology 70
Replace Patrycja Pawlikowska with:
Patrycja Pawlikowska France
Ján Gurský Czechia
Daniela Bossi Italy
Na Luo China
Mariana Lazarini Brazil
S Hoffarth Germany
Weihong Zhang China
Guillermo López-Ruano Spain
Christina Wunrau Germany
Vanessa T. Garrido United States
Simon Haefliger relative to Patrycja Pawlikowska France Patrycja Pawlikowska's profile →
Citations per field
00.5×4.5×
Patrycja Pawlikowska · 1×
Citations per year

Countries citing papers authored by Simon Haefliger

Since Specialization
Citations

This map shows the geographic impact of Simon Haefliger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Haefliger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Haefliger more than expected).

Fields of papers citing papers by Simon Haefliger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Haefliger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Haefliger. The network helps show where Simon Haefliger may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Haefliger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Haefliger Line = papers co-authored together Simon Haefliger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008136
2
Targeting and engineering long non-coding RNAs for cancer therapy
Hit paper breakdown →
2024118
3 200956
4 201050
5 201148
6 201639
7 201029
8 202426
9 202121
10 202120
11 200716
12 202214
13 202413
14 202410
15 20227
16 20237
17 20227
18 20246
19 20214
20 20173

About Simon Haefliger

Simon Haefliger is a scholar working on Cancer Research, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 33 papers that have together received 646 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cancer-related molecular mechanisms research (4 papers), Nanoparticle-Based Drug Delivery (3 papers), RNA Research and Splicing (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (198 citations), Hematology (134 citations), Genetics (59 citations), Molecular Biology (313 citations) and Oncology (70 citations). Simon Haefliger has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Julian Schardt, Thomas Pabst, Beatrice U. Mueller, Marianne Eyholzer, Rory Johnson, Michela Coan, Samir Ounzain, Nikolai A. Timchenko, Milton J. Finegold and Adrienne Vancura. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, ESMO Open, Frontiers in Bioengineering and Biotechnology and British Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact